Here you will find our projects sorted by topicality:
Efficient cell coating of biohybrid lungs by atomization of shear-stress resistant endothelial cells derived from induced pluripotent stem cells EndoSpray
Influence of a Biohybrid Lung on Inflammatory Pathways and Immune System-Endothelial Cell-Interaction EndOxy in Flame
The Optimize project aims to develop an innovative implant for the treatment of hyperplastic left heart syndrome
BioV2alve deals with the development of biohybrid venous valves for minimal invasive treatment of chronic veneous insufficiency.
The FibroGraft project focuses on the use of naturally dissolved silk fibroins in materials technology and the creation of different fibroin composites for tissue engineering.
The aim of the project Fontan is to improve the quality of life and prevent morbidity and mortality in patients in the Fontan circulation. This is to be achieved by generating an autologous, flap-bearing, contractile conduit in the sense of a subpulmonary neo-ventricle.
The aim of the Implant Monitoring project is to establish longitudinal monitoring of tissue maturation and to validate it in animal experiments. To this end, an understanding of the biological dynamics of the insertion and remodelling process of biohybrid cardiovascular implants will be gained using the example of the geometrically simple vascular prosthesis. In order to investigate the interactions between (i) biomaterial, (ii) cellular components and (iii) implant environment non-invasively, methods of hybrid MR-PET and molecular ultrasound imaging will be investigated and tested.
To improve life quality of lung cancer patients we develop biohybrid respiratory stent, PulmoStent.
In the CellSpray project, we are working on the application of an innovatice spraying process for local cell therapy of the lungs.
In the EndOxy project we are developing a biohybrid lung that enables patients with life-threatening lung failure to receive long-term lung support
The BioPacer project is developing a biological pacemaker for babies and children.Traditional pacemakers are too big for the chest.The "BioPacer" consists of a small cylinder that is populated with endogenous cells of the heart-sick child and cultivated in a bioreactor. It will treat heart rhythm disorders.